Navigation Links
Symphony Medical Changes Name to CardioPolymers, Inc.
Date:7/22/2009

LAGUNA HILLS, Calif., July 22 /PRNewswire/ -- Symphony Medical, Inc., a development-stage company focused on novel biopolymer implant therapies to treat cardiac abnormalities, announced today that it has changed the name of the corporation to CardioPolymers, Inc.

CardioPolymers, Inc. Chief Executive Officer Raymond W. Cohen said, "The name change, which is effective immediately, better reflects our focus on employing natural biocompatible polymer implants to treat cardiac patients - specifically, congestive heart failure patients with an enlarged left ventricle."

CardioPolymers is currently sponsoring a human clinical study of its patented flagship technology Algisyl-LVR(R) at world-class centers in Europe, including the German Heart Center in Munich where the first three patients were successfully treated.

Algisyl-LVR is an implantable medical device under clinical development intended to prevent or reverse the progression of congestive heart failure in patients with dilated cardiomyopathy, a condition in which the heart becomes weakened and enlarged, and cannot pump blood efficiently. The procedure involves injecting a proprietary biopolymer directly into strategic locations of the heart's left ventricle wall. As it is injected, the biopolymer thickens and forms firm, gel-like structures that remain in the heart muscle as permanent implants. These implants act to re-shape the heart, reduce the size of the dilated left ventricle and thicken the damaged wall of the heart, thus returning the heart to a healthier form that facilitates improved cardiac function and performance.

About CardioPolymers, Inc.

CardioPolymers, Inc., a Delaware Corporation (formerly known as Symphony Medical) was founded in 2003 and is headquartered in Orange Coun
'/>"/>

SOURCE CardioPolymers, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
2. Symphony Managemnt Consulting Hires New Solutions Director
3. Angiotech and Symphony Medical Announce Licensing Agreement
4. Environmental Tectonics Corporation Announces Promotion of Don R. Webber to VP of Sales for their BioMedical Division
5. Regado Biosciences Expands Medical Advisory Board
6. BioMS Medical announces second quarter 2009 results
7. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
8. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
9. Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
10. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
11. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... DNA Genotek, a leading provider of products for...t Tepnel Pharmaceutical Services will offer Oragen...ucleic acid extraction and genotyping service. , ...r 1, 2009 -- DNA Genotek , a leading provider of ...nnounced that Tepnel Pharmaceutical Services wil...
(Date:12/1/2009)... The two humanitarian organizations will collabo... biomedical repair technologies. Their shared effo... country of Togo. , Dalla...signing of a Memorandum of Understanding, Mercy Sh...artnership to help develop sustainable infrastruct...
(Date:12/1/2009)... California waste-to-energy firm claims first pl...eration, smallest footprint, salable pure gas, byp... (PRWEB) December 15, 2009 -- The ...tive organic waste-to-energy process will take pla...uary. , , ,This biowaste process known as VRAD&co...
(Date:11/30/2009)...Ohio, Nov. 30 The Ohio Capital Fun...ion,s first minority business early-stage capital ...ber 3, is called "Transforming the Landscape of Bu... Capital Summit." It will feature several speakers...eaders and local minority entrepreneurs. ,, "T...
Breaking Biology Technology:Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3First Public Showing of Innovative Waste-to-Energy Process 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
...Jersey, December 5, Rosetta Genomics, Ltd. (NASDAQ...pany leveraging microRNAs as biomarkers,reported t...arter ended,September 30, 2008 and business highli...e third quarter of 2008 of $705,000.,These revenue...rkway Clinical,Laboratories at the end of July thr...
...c.,(Nasdaq: MDVN ) today announced that David Hu...ill be a featured speaker on two panels at the RBC...rsday, December 11, in New York: , -- "Wagin...tern Time, -- "The Challenge of Alzheimer,s Dis... A live audio webcast of each panel will be ...
... 4 Octapharma,Chairman Wolfgang Marguerre today a...o lead Octapharma,s plasma operations in the Unite...counsel since 2002 and will now serve as,President...ivate plasma products company in the world, Octaph...nta company that operates 12,plasma centers in the...
Other Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2
(Date:11/30/2009)...roteins are crucial for infection. Each binds a sp...ch stimulates the host cell to take up the pathoge...erent function, for example the regulation of cell...e now been published in the current issue of the "...is one of the sources for Listeria infections le...
(Date:11/30/2009)...stress of seeing your extended family over the hol...ch report in the December 2009 print issue of the ...io.org ) shows that you might be right. Here,s the... to entirely new treatments that help keep autoimm...er control. That,s because researchers from the Un...
(Date:11/26/2009)...me of the Ocean,s most distinctive residents. ,Eve...ge head shape, says Michelle McComb from Florida ...ark,s vision. ,Perhaps their visual field has been... giving the sharks excellent stereovision and dept...were two schools of thought on this theory. In 194...
Breaking Biology News(10 mins):It takes 2 to infect 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Wide heads give hammerheads exceptional stereo view 2The Chopra Center Press Set to Release New Book this June 25 49801 1The Chopra Center Press Set to Release New Book this June 25 49801 2The Chopra Center Press Set to Release New Book this June 25 49801 3A Canada wide technology platform for mapping the human interactome 8974 1A Canada wide technology platform for mapping the human interactome 8974 2Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 1Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 2Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 3
...Researchers at New York University,s Courant Insti... algorithm that enhances the ability to detect a c...p the set of tumor-suppressor genes involved in lu...,s gene-chips that can scan hundreds of patients, ...he findings will appear in the July issue of the A...
...Knee cartilage injuries can be effectively repaire...t stop the regeneration process concludes research... The study, "Maturation of tissue engineered carti... knees", published in the July 2006 (Volume 12, Nu...that engineered cartilage tissue can grow and matu...
...Bacteria like Salmonella have a complicated immune...ign DNA trying to invade their cell membrane, acco...he June 8 issue of Science Express. The research, ...l Cancer Center in San Diego, could have major imp...se-causing bacteria. The findings may also impact ...
Other Biology News:NYU algorithm enhances ability to detect cancer genes 2NYU algorithm enhances ability to detect cancer genes 3Bacteria have their own immune system protecting against outside DNA 2
Sheep Anti-Human Vesicle Associated Membrane Protein (VAMP 1/2) Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited
Feline IFN-alpha, Unconjugated from R&D Systems
...A Development kit contains the basic components re...easure natural and recombinant canine Monocyte Che...tes and serum.1 Each kit contains sufficient mater...l plates, provided that the following conditions a...
Biology Products: